Company Radient Technologies Inc Toronto S.E.
Equities
CA75034P1062
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Soluble Products
100.0
%
| 2 | 96.8 % | 4 | 100.0 % | +50.37% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 2 | 100.0 % | 4 | 100.0 % | +45.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Splinter
FOU | Founder | - | 01-06-11 |
Director of Finance/CFO | - | 14-05-21 | |
Zachary Riauka
COO | Chief Operating Officer | - | - |
Jan Petzel
BRD | Director/Board Member | 51 | 16-12-22 |
Christian Aigner
PRN | Corporate Officer/Principal | - | - |
Dave Rohachuk
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 14-05-21 | |
Steven Splinter
FOU | Founder | - | 01-06-11 |
Jan Petzel
BRD | Director/Board Member | 51 | 16-12-22 |
Dimitris Tzanis
BRD | Director/Board Member | - | 16-07-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 541,000,000 | 540,868,021 ( 99.98 %) | 0 | 99.98 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+38.97% | 6.09B | |
-22.28% | 4.14B | |
+3.48% | 3.23B | |
-19.51% | 2.83B | |
-7.29% | 2.39B | |
+42.43% | 1.9B | |
-4.71% | 1.57B | |
-15.15% | 1.55B | |
-14.86% | 1.5B |